Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines.

Atici, Serkan; Soysal, Ahmet; Gönüllü, Erdem; Aydemir, Gökhan; Öner, Naci; Alan, Servet; Engin, Havva; Yildiz, Melek; Karaböcüoglu, Metin

Atici, Serkan; Soysal, Ahmet; Gönüllü, Erdem; Aydemir, Gökhan; Öner, Naci; Alan, Servet; Engin, Havva; Yildiz, Melek; Karaböcüoglu, Metin.

Afiliação

Atici S; Okan University School of Medicine, Division of Pediatric Infectious Diseases, Istanbul, Turkey.
Soysal A; Memorial Atasehir Hospital, Division of Pediatric Infectious Diseases, Istanbul, Turkey.
Gönüllü E; Istanbul Health and Technology University, Department of Pediatrics, Istanbul, Turkey.
Aydemir G; Haliç University, Department of Pediatrics, Istanbul, Turkey.
Öner N; Istanbul Health and Technology University, Department of Pediatrics, Istanbul, Turkey.
Alan S; Memorial Atasehir Hospital, Clinic of Infectious Diseases, Istanbul, Turkey.
Engin H; Memorial Atasehir Hospital, Clinic of Infectious Diseases, Istanbul, Turkey.
Yildiz M; Memorial Sisli Hospital, Clinic of Infectious Diseases, Istanbul, Turkey.
Karaböcüoglu M; Biruni University, Department of Pediatrics, Istanbul, Turkey.

Rev Soc Bras Med Trop ; 56: e00462023, 2023.

Article em En | MEDLINE | ID: mdl-37493731

Assuntos

Vacina BNT162; COVID-19; Humanos; Vacinas contra COVID-19; Imunidade Humoral; COVID-19/prevenção & controle; Anticorpos Neutralizantes; Imunoglobulina G; RNA Mensageiro; Anticorpos Antivirais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article